Q2 2022 Holdings
Filed 2022-08-15 | 88 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $703.5M | 7,567,900 | 57.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $148.3M | 727,024 | 12.2% |
| Cytek Biosciences Inc(CTKB) | COM | 23285D109 | $143.6M | 13,381,054 | 11.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $61.4M | 4,398,453 | 5.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $55.9M | 2,075,000 | 4.6% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $45.9M | 9,770,773 | 3.8% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $29.1M | 3,748,389 | 2.4% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $6.4M | 2,589,904 | 0.5% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $6.4M | 756,821 | 0.5% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $6.0M | 500,000 | 0.5% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $4.7M | 383,028 | 0.4% |
| Cvrx Inc(CVRX) | COM | 126638105 | $1.7M | 275,000 | 0.1% |
| Aerovate Therapeutics Inc | COM | 008064107 | $129.2K | 8,263,982 | 0.0% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $126.0K | 7,040,622 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $119.3K | 4,922,941 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $105.9K | 8,670,644 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $99.7K | 4,581,203 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $97.8K | 21,741,458 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $96.2K | 7,805,129 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $94.5K | 10,230,274 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $91.0K | 4,417,259 | 0.0% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $89.3K | 7,900,000 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $80.8K | 5,208,911 | 0.0% |
| Pepgen Inc(PEPG) | COM | 713317105 | $80.8K | 8,131,952 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $62.1K | 9,011,651 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $61.3K | 9,003,018 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $55.9K | 17,202,009 | 0.0% |
| VOR Biopharma Inc | COM | 929033108 | $55.3K | 11,120,973 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $53.8K | 4,264,144 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $51.7K | 7,236,454 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $48.9K | 4,898,373 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $46.7K | 30,126,299 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $46.4K | 1,310,289 | 0.0% |
| Nanostring Technologies(NSTGEUR) | COM | 63009R109 | $45.5K | 3,584,478 | 0.0% |
| Rxsight Inc(RXST) | COM | 78349D107 | $43.0K | 3,052,796 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $42.4K | 896,724 | 0.0% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $39.7K | 13,150,849 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $38.0K | 2,000,000 | 0.0% |
| Instil BIO Inc | COM | 45783C101 | $35.4K | 7,670,793 | 0.0% |
| Icosavax Inc | COM | 45114M109 | $34.2K | 5,963,565 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $31.5K | 2,167,391 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $30.6K | 2,186,636 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $29.0K | 2,107,149 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $26.5K | 3,370,506 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $25.1K | 7,782,669 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $24.5K | 5,914,252 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $24.4K | 1,710,265 | 0.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $21.5K | 1,578,820 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $21.4K | 5,100,000 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $20.2K | 4,871,067 | 0.0% |